BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36807179)

  • 1. [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytology].
    Hirano N; Aoki S; Mizuma M; Nakagawa K; Inoue K; Iseki M; Nakayama S; Douchi D; Miura T; Ishida M; Ohtsuka H; Morikawa T; Ohnuma S; Kamei T; Unno M
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):224-226. PubMed ID: 36807179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GEM + nab-PTX Therapy for Pancreatic Body Cancer cStage IVb for Conversion Surgery: A Case Report.
    Yoshii H; Izumi H; Abe R; Tajiri T; Mukai M; Nomura E; Makuuchi H
    Tokai J Exp Clin Med; 2019 Dec; 44(4):85-89. PubMed ID: 31768996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Radical Resection for Locally Advanced Pancreatic Cancer with Positive Peritoneal Cytology Treated with Chemoradiotherapy].
    Sato R; Takizawa K; Yuza K; Soma D; Hirose Y; Morimoto Y; Miura K; Nagahashi M; Takano K; Sakata J; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Wakai T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2385-7. PubMed ID: 26805372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conversion Surgery for Pancreatic Head Cancer with Peritoneal Dissemination Following Chemotherapy for Two Years - A Case Report].
    Hatsuzawa Y; Mizuma M; Motoi F; Hata T; Iseki M; Takadate T; Ohtsuka H; Sakata N; Morikawa T; Nakagawa K; Hayashi H; Naitoh T; Kanno A; Shimosegawa T; Unno M
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):347-349. PubMed ID: 29483443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting positive peritoneal cytology in pancreatic cancer.
    O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report].
    Nakamoto S; Nishiyama R; Kaneda T; Yokota M; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Yamauchi H; Okuwaki K; Iwai T; Imaizumi H; Suzuki E; Hara A; Ichinoe M; Kida M; Watanabe M
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):173-176. PubMed ID: 28223678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total Pancreatectomy for Remnant Pancreatic Cancer with Positive Washing Cytology after Conversion to Negative Cytology Following Gemcitabine plus Nab-Paclitaxel Therapy-A Case Report].
    Nakajima K; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1681-1683. PubMed ID: 36733175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
    Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
    Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Long-Term Survival in a Patient with Recurrence of Peritoneal Dissemination after Resection of Pancreatic Tail Cancer].
    Aoki Y; Suzuki D; Furukawa K; Takayashiki T; Kuboki S; Takano S; Sakai N; Kagawa S; Hosokawa I; Mishima T; Konishi T; Otsuka M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2201-2203. PubMed ID: 33468907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
    Kimura H; Fushida S; Mukawa A
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1191-4. PubMed ID: 19620816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case Report of Pancreatic Tail Carcinoma with Positive Periotoneal Washing Cytology with Recurrence-Free Survival after Surgery and Chemotherapy].
    Taida S; Owada Y; Okazaki T; Manabe Y; Nakanishi R; Tachibana T; Tokuhara K; Tsuneki T; Ikeda T; Hosono M; Sendo H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1982-1984. PubMed ID: 38303272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-Term Survival following Multidisciplinary Therapy for Unresectable Pancreatic Body Cancer].
    Mineta S; Okada T; Sanuki F; Iwamoto R; Kitagawa S; Kinoshita S; Ueno M; Kubota H; Tanaka H; Higashida M; Ito Y; Endo S; Yoshimatsu K; Fujiwara Y; Ueno T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1814-1816. PubMed ID: 36733008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review.
    Kobayashi Y; Maeda S; Hama N; Miyamoto A; Uemura M; Miyake M; Nishikawa K; Hirao M; Kato T; Sekimoto M; Mori K; Mano M; Nakamori S
    Int Cancer Conf J; 2018 Jan; 7(1):20-25. PubMed ID: 31149507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Successful Adjuvant Surgery for the Pancreas Head Cancer with Peritoneal Metastasis].
    Kyakumoto Y; Takadate T; Mizuma M; Hata T; Iseki M; Ohtsuka H; Sakata N; Nakagawa K; Morikawa T; Hayashi H; Motoi F; Naitoh T; Kanno A; Shimosegawa T; Unno M
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1880-1882. PubMed ID: 29394807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
    Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
    Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
    Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.
    Tanaka N; Takami H; Hayashi M; Inokawa Y; Kurimoto K; Hattori N; Kanda M; Tanaka C; Nakayama G; Kodera Y
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1273-1281. PubMed ID: 37799038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
    Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
    Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Conversion Surgery after Long-Term Chemotherapy for Pancreatic Cancer with Peritoneal Metastasis].
    Enoki M; Gotoh K; Sakai K; Toshiyama R; Yanagisawa K; Kawai K; Miyo M; Takahashi Y; Hamakawa T; Doi T; Takeno A; Katoh T; Takami K; Hirao M
    Gan To Kagaku Ryoho; 2023 Jan; 50(1):87-89. PubMed ID: 36759995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.